Selvita Becomes First CRO to License Medicines Discovery Catapult's Patented Target Engagement Technology
Selvita has become the first contract research organization to license Medicines Discovery Catapult's Chemical Protein Stability Assay (CPSA), a patented technology designed to accelerate drug candidate identification and prioritization.